184 related articles for article (PubMed ID: 26788051)
1. Decreased Circulating T Regulatory Cells in Egyptian Patients with Nonsegmental Vitiligo: Correlation with Disease Activity.
Hegab DS; Attia MA
Dermatol Res Pract; 2015; 2015():145409. PubMed ID: 26788051
[TBL] [Abstract][Full Text] [Related]
2. Effect of narrow band-ultraviolet B on CD4(+) CD25(high) FoxP3(+) T-lymphocytes in the peripheral blood of vitiligo patients.
Moftah NH; El-Barbary RA; Ismail MA; Ali NA
Photodermatol Photoimmunol Photomed; 2014 Oct; 30(5):254-61. PubMed ID: 24372806
[TBL] [Abstract][Full Text] [Related]
3. Assessment of tissue FoxP3+, CD4+ and CD8+ T-cells in active and stable nonsegmental vitiligo.
Abdallah M; Lotfi R; Othman W; Galal R
Int J Dermatol; 2014 Aug; 53(8):940-6. PubMed ID: 24527781
[TBL] [Abstract][Full Text] [Related]
4. Alteration in regulatory T cells and programmed cell death 1-expressing regulatory T cells in active generalized vitiligo and their clinical correlation.
Tembhre MK; Parihar AS; Sharma VK; Sharma A; Chattopadhyay P; Gupta S
Br J Dermatol; 2015 Apr; 172(4):940-50. PubMed ID: 25376752
[TBL] [Abstract][Full Text] [Related]
5. Altered expression of nuclear factor of activated T cells, forkhead box P3, and immune-suppressive genes in regulatory T cells of generalized vitiligo patients.
Giri PS; Dwivedi M; Laddha NC; Begum R; Bharti AH
Pigment Cell Melanoma Res; 2020 Jul; 33(4):566-578. PubMed ID: 31917889
[TBL] [Abstract][Full Text] [Related]
6. Meta-Analysis of Alterations in Regulatory T Cells' Frequency and Suppressive Capacity in Patients with Vitiligo.
Giri PS; Mistry J; Dwivedi M
J Immunol Res; 2022; 2022():6952299. PubMed ID: 36164321
[TBL] [Abstract][Full Text] [Related]
7. Impact of CD4+CD25high regulatory T-cells and FoxP3 expression in the peripheral blood of patients with systemic lupus erythematosus.
Atfy M; Amr GE; Elnaggar AM; Labib HA; Esh A; Elokely AM
Egypt J Immunol; 2009; 16(1):117-26. PubMed ID: 20726328
[TBL] [Abstract][Full Text] [Related]
8. FOXP3 demethylation as a means of identifying quantitative defects in regulatory T cells in acute coronary syndrome.
Lü CX; Xu RD; Cao M; Wang G; Yan FQ; Shang SS; Wu XF; Ruan L; Quan XQ; Zhang CT
Atherosclerosis; 2013 Jul; 229(1):263-70. PubMed ID: 23735638
[TBL] [Abstract][Full Text] [Related]
9. Deficient CD4+CD25+ T regulatory cell function in patients with abdominal aortic aneurysms.
Yin M; Zhang J; Wang Y; Wang S; Böckler D; Duan Z; Xin S
Arterioscler Thromb Vasc Biol; 2010 Sep; 30(9):1825-31. PubMed ID: 20448211
[TBL] [Abstract][Full Text] [Related]
10. Enhanced Th1 and Th17 responses in peripheral blood in active non-segmental vitiligo.
Zhen Y; Yao L; Zhong S; Song Y; Cui Y; Li S
Arch Dermatol Res; 2016 Dec; 308(10):703-710. PubMed ID: 27687555
[TBL] [Abstract][Full Text] [Related]
11. Role of regulatory CD4+CD25+ Foxp3 T cells in bronchial asthma in Egyptian children.
Bakr SI; Mahran MZ; Soliman DA
Egypt J Immunol; 2013; 20(2):29-38. PubMed ID: 24617045
[TBL] [Abstract][Full Text] [Related]
12. Analysis of FOXP3
Schmidt A; Rieger CC; Venigalla RK; Éliás S; Max R; Lorenz HM; Gröne HJ; Krammer PH; Kuhn A
Immunol Res; 2017 Apr; 65(2):551-563. PubMed ID: 28224362
[TBL] [Abstract][Full Text] [Related]
13. Serum levels of functional T-regs in vitiligo: our experience and mini-review of the literature.
Richetta A; D'Epiro S; Salvi M; Campoli M; Giancristoforo S; Mattozzi C; Macaluso L; Luci C; Cantisani C; Carboni V; Zanniello R; Zampetti M; Milana B; Morrone S; Calvieri S
Eur J Dermatol; 2013 Apr; 23(2):154-9. PubMed ID: 23608724
[TBL] [Abstract][Full Text] [Related]
14. Increased numbers of FoxP3-expressing CD4+ CD25+ regulatory T cells in peripheral blood from dogs with atopic dermatitis and its correlation with disease severity.
Hauck V; Hügli P; Meli ML; Rostaher A; Fischer N; Hofmann-Lehmann R; Favrot C
Vet Dermatol; 2016 Feb; 27(1):26-e9. PubMed ID: 26748886
[TBL] [Abstract][Full Text] [Related]
15. Harmine and Kaempferol treatment enhances NFATC1 and FOXP3 mediated regulatory T-cells' suppressive capacity in generalized vitiligo.
Giri PS; Bharti AH; Kode J; Begum R; Dwivedi M
Int Immunopharmacol; 2023 Dec; 125(Pt B):111174. PubMed ID: 37951194
[TBL] [Abstract][Full Text] [Related]
16. Systemic analyses of immunophenotypes of peripheral T cells in non-segmental vitiligo: implication of defective natural killer T cells.
Zhou L; Li K; Shi YL; Hamzavi I; Gao TW; Henderson M; Huggins RH; Agbai O; Mahmoud B; Mi X; Lim HW; Mi QS
Pigment Cell Melanoma Res; 2012 Sep; 25(5):602-11. PubMed ID: 22591262
[TBL] [Abstract][Full Text] [Related]
17. Global activation of CD8+ cytotoxic T lymphocytes correlates with an impairment in regulatory T cells in patients with generalized vitiligo.
Lili Y; Yi W; Ji Y; Yue S; Weimin S; Ming L
PLoS One; 2012; 7(5):e37513. PubMed ID: 22649532
[TBL] [Abstract][Full Text] [Related]
18. CD4+CD25+CD127low FoxP3+ regulatory T cells in Crohn's disease.
Khalili A; Ebrahimpour S; Maleki I; Abediankenari S; Afrouzi MM
Rom J Intern Med; 2018 Sep; 56(3):158-166. PubMed ID: 29453928
[TBL] [Abstract][Full Text] [Related]
19. Levels of TGF-β(1) in serum and culture supernatants of CD4(+)CD25 (+) T cells from patients with non-segmental vitiligo.
Tu CX; Jin WW; Lin M; Wang ZH; Man MQ
Arch Dermatol Res; 2011 Nov; 303(9):685-9. PubMed ID: 21644048
[TBL] [Abstract][Full Text] [Related]
20. Two separate effects contribute to regulatory T cell defect in systemic lupus erythematosus patients and their unaffected relatives.
Costa N; Marques O; Godinho SI; Carvalho C; Leal B; Figueiredo AM; Vasconcelos C; Marinho A; Moraes-Fontes MF; Gomes da Costa A; Ponte C; Campanilho-Marques R; Cóias T; Martins AR; Viana JF; Lima M; Martins B; Fesel C
Clin Exp Immunol; 2017 Sep; 189(3):318-330. PubMed ID: 28542701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
